UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Down 5.0% Today

What is UnitedHealth Group Incorporated (DE)?

UnitedHealth Group (UNH): UnitedHealth Group (UNH) is a diversified healthcare company that offers health insurance services through its UnitedHealthcare segment and healthcare services via Optum. Today, UNH experienced a bearish movement, closing down 2.64%.

Why is UnitedHealth Group Incorporated (DE) going down?

UNH stock is down 5.0% on Feb 24, 2026 15:06

• UNH stock dipped 2.64% today, underperforming broader market indices like the S&P 500, Dow, and Nasdaq.
• Analysts anticipate a decline in EPS for the upcoming release, signaling potential concerns about the company's financial performance.
• The bearish movement could be attributed to general market volatility, concerns about healthcare regulatory risks, and potentially lower-than-expected financial results for the company.

UNH Price Chart

UNH Technical Analysis

UNH News

DaVita Stock After Earnings: Hidden Cash Machine or Value Trap?

DaVita Inc. has once again beaten Wall Street earnings expectations and shown strong cash flow, yet its stock trades at a discount due to regulatory concerns and fears about GLP-1 weight-loss drugs. Despite these challenges, analysts are cautiously optimistic, highlighting resilient fundamentals, robust free cash flow, and potential for higher returns if regulatory fears are overblown. The article suggests that DaVita could be a valuable, albeit volatile, addition to a diversified healthcare portfolio for investors willing to accept policy-driven risks.

https://www.ad-hoc-news.de/boerse/news/ueberblick/davita-stock-after-earnings-hidden-cash-machine-or-value-trap/68607321

How Investors May Respond To Humana (HUM) Weaker EPS And Affirmed Dividend In 2026 Outlook

Humana Inc. reported weaker Q4 2025 results and a soft 2026 GAAP EPS outlook, yet affirmed its quarterly dividend of US$0.885 per share. This decision signals the company's commitment to shareholder returns despite profitability challenges, as it focuses on medical cost control, Star ratings, and value-based care within its Medicare-centric model. Investors are left to weigh the affirmed dividend against the backdrop of short-term earnings pressures and evolving regulatory risks.

https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/how-investors-may-respond-to-humana-hum-weaker-eps-and-affir

UnitedHealth Group (UNH) Dips More Than Broader Market: What You Should Know

UnitedHealth Group (UNH) experienced a dip, closing at $282.34, down 2.64% and underperforming broader market indices like the S&P 500, Dow, and Nasdaq. Despite recent losses, analysts anticipate an EPS of $6.76 for the upcoming release, though this represents a 6.11% decline year-over-year. The company currently holds a Zacks Rank of #3 (Hold) and trades at a Forward P/E ratio of 16.4.

https://uk.finance.yahoo.com/news/unitedhealth-group-unh-dips-more-224503994.html

New cancer and prenatal tests aimed to drive growth at Myriad Genetics

Myriad Genetics reported Q4 2025 revenue of $209.8 million and reiterated its 2026 financial guidance for $860–$880 million in revenue, driven by existing tests like Prolaris and GeneSight, and three new test launches planned for 2026. The company saw a significant positive market reaction, with its stock gaining 19.41% following the news. Despite a slight decline in full-year 2025 revenue and continued impact on GeneSight due to discontinued coverage by UnitedHealthcare, Myriad highlighted strengthened execution and strategic investments in its precision oncology and women's health pipelines.

https://www.stocktitan.net/news/MYGN/myriad-genetics-reports-fourth-quarter-and-full-year-2025-financial-setx5kkeyszk.html

CVS employee bonuses surge after beating 2025 profit target

CVS Health Corp. has increased bonuses for its corporate employees by 42.3 percent above baseline levels for 2025, a significant turnaround from the previous year. This surge is attributed to new CEO David Joyner's success in controlling costs within the Aetna insurance unit and improving overall operations, leading the company to exceed its adjusted operating income targets. The bonus structure is based on adjusted operating income, operational expenses to revenue ratio, and customer loyalty (Net Promoter Score).

https://www.bostonglobe.com/2026/02/23/business/cvs-employee-bonuses-profit-target/

Trending Today

Ethereum ($ETH) Crypto Forecast: Down 5.5% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.3% Today

UnitedHealth Group Incorporated (DE) Price History

30.09.2025 - UNH Stock was down 4.6%

• Despite impressive financial performance in revenue and profit growth, UnitedHealth's stock faced downward pressure.
• Investor concerns about the potential loss of tens of thousands of enrollees in commercial and Medicaid plans may have contributed to the market's negative response.
• Mixed third-quarter results, characterized by a revenue shortfall but an improved EPS forecast, likely fueled uncertainty among investors and the bearish market trend.
• The impact of rising medical costs on profits, despite strong growth in commercial membership, may have also influenced the market's reaction.

05.00.2026 - UNH Stock was up 1.0%

• UnitedHealth Group's strong bullish movement today can be attributed to positive developments in the healthcare and insurance sectors.
• The increase in price target for Humana, a competitor in the healthcare industry, indicates overall optimism and potential growth in the sector, which could have positively impacted UNH's stock.
• UnitedHealth Group retaining its lead position in net premiums written showcases its strong market position and stability, likely contributing to investor confidence and buying interest in the stock.
• Despite a reduction in stake by City Holding Co., the overall institutional investment in the company and its strong financial performance, including surpassing earnings estimates and announcing a dividend, could have outweighed this sell-off, driving the stock price higher.

24.01.2026 - UNH Stock was down 5.0%

• UNH stock dipped 2.64% today, underperforming broader market indices like the S&P 500, Dow, and Nasdaq.
• Analysts anticipate a decline in EPS for the upcoming release, signaling potential concerns about the company's financial performance.
• The bearish movement could be attributed to general market volatility, concerns about healthcare regulatory risks, and potentially lower-than-expected financial results for the company.

24.01.2026 - UNH Stock was down 5.2%

• Today's bearish movement in UNH stock could be explained by:
• Concerns related to regulatory challenges and policy uncertainties impacting the healthcare sector, leading to a broader decline in healthcare stocks.
• DaVita Inc.'s strong earnings report and potential as a competitor in the healthcare space possibly diverting investor attention away from UNH.
• Weaker-than-expected earnings from Humana Inc. and the changing regulatory landscape in the healthcare industry potentially influencing negative market sentiment towards UNH and other healthcare stocks.
• The focus on affordability and value-based care in the healthcare industry, as emphasized by Humana's President, possibly raising worries about profit margins for companies like UNH amidst rising cost pressures.

02.00.2026 - UNH Stock was up 2.6%

• SteelPeak Wealth LLC increased its stake in UNH, showcasing confidence in the company's future and contributing to positive market sentiment.
• Although Allspring Global Investments Holdings LLC reduced its holdings in UNH, other institutional investors have displayed interest in the company, reflecting overall market confidence in the stock.
• UNH is making operational changes post external audits to enhance efficiency and tackle issues impacting profit forecasts, a move that could be positively viewed by investors.
• Concerns surrounding Medicare Advantage risks and reimbursement pressures affecting Humana's stock may have indirectly favored UNH as investors pursue more stable investment options in the healthcare industry.

27.00.2026 - UNH Stock was down 17.8%

• UNH stock showed bearish movement, potentially due to profit-taking following a recent uptrend.
• Positive earnings from Sysco Corp. and the all-time high of CH Robinson Worldwide Inc could have shifted investor focus away from UNH.
• The mixed performance of Dow Jones and Nasdaq futures, with tech earnings in focus, might have influenced market sentiment, impacting UNH negatively.
• The appointment of a new Chief Legal Officer at Central Garden & Pet may have generated positive sentiment for the company, diverting attention from UNH.

27.00.2026 - UNH Stock was down 17.7%

• The bearish movement in UnitedHealth Group (UNH) stock today can be attributed to the following factors:
• Despite the overall market showing mixed movements, specific healthcare stocks like UnitedHealth Group may have faced pressure due to concerns about potential regulatory changes or shifts in healthcare policies.
• The underperformance of UnitedHealth Group could also be influenced by company-specific factors such as lower-than-expected earnings, increased competition in the healthcare sector, or changes in reimbursement rates.
• Investors might be rotating out of healthcare stocks like UnitedHealth Group and into other sectors like technology, as indicated by the positive movements in tech stocks like Cloudflare Inc. and EquipmentShare.com Inc. in pre-market trading.
• The market may be reacting to news about other companies like Sysco Corp. beating earnings expectations, leading investors to reallocate their investments away from healthcare and into sectors with stronger financial performance.

27.00.2026 - UNH Stock was down 19.2%

• The stock of UnitedHealth faced significant downward movement today due to lower-than-expected reimbursement rates proposed by the Trump administration for 2027 in the Medicare Advantage sector.
• UnitedHealth's Q4 report did not meet the expectations of analysts, contributing to the decline in its stock price.
• Morningstar highlighted the continued regulatory hurdles faced by UnitedHealth in its Medicare Advantage and pharmacy benefit management divisions, adding to market uncertainty.
• In the broader sector, concerns were exacerbated by Centene's notable stock decrease following the announcement of unanticipated flat payment increases for Medicare Advantage in 2027 by federal regulators.

27.00.2026 - UNH Stock was down 19.5%

• UnitedHealth's decline in the market is linked to its intention to decrease Medicare Advantage benefits following reduced reimbursement rates proposed for 2027.
• The stock's drop was also influenced by the negative response to UnitedHealth's earnings report, which did not meet Street expectations.
• The health insurance sector as a whole, including companies like Elevance Health and CVS Health, is grappling with issues such as stagnant Medicare Advantage rates and regulatory investigations, resulting in a downturn for the sector.
• Despite UnitedHealth's 2026 profit forecast aligning with projections, ongoing regulatory obstacles in its Medicare Advantage and pharmacy benefit management divisions are causing uncertainty among investors, potentially delaying a significant profit improvement.

27.00.2026 - UNH Stock was down 19.6%

• UnitedHealth Group's stock experienced a significant bearish movement of 19% following its Q4 2025 earnings report, where GAAP earnings saw a drastic year-over-year decline.
• The market reacted negatively to the news of UnitedHealth's plummeting GAAP earnings, which raised concerns about the company's financial performance and outlook.
• The downward pressure on UNH stock was further intensified by the broader market sentiment towards health insurance companies, as evidenced by the decline in Elevance Health (ELV) stock following UnitedHealth's earnings report.
• Despite the current sell-off, UnitedHealth Group remains optimistic about a potential rebound in GAAP earnings for 2026, which could present a buying opportunity for investors looking at the long-term growth prospects of the company.

18.10.2025 - UNH Stock was down 5.0%

• The bearish movement in UNH stock could be attributed to the bearish approach adopted by deep-pocketed investors towards the company, as highlighted in the options market analysis.
• The decrease in short interest as a percent of float may have also contributed to the downward pressure on UNH stock, indicating reduced market optimism towards the company.
• Despite positive news surrounding other companies in the healthcare sector, the specific bearish sentiment towards UnitedHealth Group seems to have weighed down its stock performance today.

12.10.2025 - UNH Stock was up 5.4%

• UNH saw a 9.6% decrease in its stock value post Q3 earnings beat, as concerns related to escalating medical expenses and margin pressure tested investor resilience.
• Options trading on UNH reflected a mix of positive and negative sentiments from affluent investors, contributing to heightened stock volatility.
• Notably, sizable investors endorsing bullish positions in UNH potentially influenced the robust market upsurge observed.
• The interplay between conflicting options trends and investor reactions to financial performance likely influenced UNH's market performance.